50 Results for "

aticancer

" in MedChemExpress (MCE) Product Catalog:
Products (50)

50 Results for "aticancer" in MCE Product Catalog:

Cat. No.: HY-114002
CAS No.: 135882-37-0
Purity:  99.01%
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent 129 (Compound 3a), a quinoline derivative, predicting to has anti-cancer activity .
loading...
    loading...
Cat. No.: HY-115963
CAS No.: 69123-54-2
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent 38 (compound 19), a sulfonylurea derivative, is a potent anticancer agent. Anticancer agent 38 inhibits A431 cell growth with an IC50 of 5.2 µg/mL .
loading...
    loading...
Cat. No.: HY-119324
CAS No.: 1841421-67-7
Target:  

Apoptosis

Research Areas:  

Others

Anticancer agent 254 (compound 10) is a dichloroacetic acid-loaded compound with enhanced antitumor activity against leukemia cells in vitro and better stability in vivo, and can be considered for preclinical evaluation of cancer inhibition.
loading...
    loading...
Cat. No.: HY-139252
CAS No.: 2251753-61-2
Purity:  97.1%
Research Areas:  

Cancer

Anticancer agent 225 (Comp 51) is a triterpenoic acids analogue which exhibits suppressive effect on elimination of different type of cancer stem cells (CSCs) and increase the ROS level of CSCs. Anticancer agent 225 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-146030
CAS No.: 2426686-17-9
Purity:  95.73%
Target:  

Others

Research Areas:  

Cancer

Anticancer agent 46 is an anti cancer agent. Anticancer agent 46 can be used in the research of gastric cancer .
loading...
    loading...
Cat. No.: HY-108887
CAS No.: 1884226-20-3
Target:  

Raf

Research Areas:  

Cancer

Anticancer agent 124 is an orally active, highly selective and potent pan RAF inhibitor. Anticancer agent 124 inhibits MAPK signalling in BRAF V600E, NRAS and KRAS mutant tumor cells .
loading...
    loading...
Cat. No.: HY-115942
CAS No.: 2907774-89-2
Target:  

CDK

Research Areas:  

Cancer

Anticancer agent 29 (Compd E/Z-6f) is an anticancer agent, with IC50 values of 0.054 μM, 0.127 μM, 0.129 μM, 0.396 μM for CDK2, CDK1, CDK4 and CDK6, respectively .
loading...
    loading...
Cat. No.: HY-115943
CAS No.: 2907774-88-1
Target:  

CDK

Research Areas:  

Cancer

Anticancer agent 30 (compound 6f-Z), a 3-arylidene-2-oxindole derivative, is a selective CDK2 inhibitor with potent anticancer activity .
loading...
    loading...
Cat. No.: HY-115959
CAS No.: 2379335-06-3
Target:  

Bacterial

Research Areas:  

Inflammation/Immunology Cancer

Anticancer agent 34 (compound 9), a sulfonylurea derivative, is a potent antimicrobial and anticancer agent. Anticancer agent 34 inhibits the microbial growth of B. mycoides, E. coli, and C. albicans with a MIC between 0.156 and 0.039 mg/ml. Anticancer agent 34 inhibits A549, PC3 cell growth with IC50s of 8.4 µg/ml, 7.8 µg/ml, respectively .
loading...
    loading...
Cat. No.: HY-115960
CAS No.: 2902563-75-9
Target:  

Others

Research Areas:  

Cancer

Anticancer agent 35 (compound 10), a sulfonylurea derivative, is a potent anticancer agent. Anticancer agent 35 inhibits A549, A431, PACA2 cell growth with IC50s of 18.1 µg/mL, 4.0 µg/mL, 18.9 µg/mL, respectively .
loading...
    loading...
Cat. No.: HY-115961
CAS No.: 2902563-76-0
Target:  

Bacterial

Research Areas:  

Inflammation/Immunology Cancer

Anticancer agent 36 (compound 11), a sulfonylurea derivative, is a potent antimicrobial and anticancer agent. Anticancer agent 36 inhibits the microbial growth of B. mycoides, E. coli, and C. albicans with a MIC between 0.156 and 0.039 mg/L. Anticancer agent 36 inhibits A549, PC3 cell growth with IC50s of 19.7 µg/mL, 11.9 µg/mL, respectively .
loading...
    loading...
Cat. No.: HY-115962
CAS No.: 905783-28-0
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent 37 (compound 18), a sulfonylurea derivative, is a potent anticancer agent. Anticancer agent 37 inhibits HePG2 cell growth with an IC50 of 17.2 µg/mL .
loading...
    loading...
Cat. No.: HY-116904
CAS No.: 1983924-33-9
Target:  

Apoptosis Akt

Research Areas:  

Cancer

Anticancer agent 253 (Compound 26) has anti-cancer activity against breast cancer cells, with IC50s of 6 μM (MCF-7), 10 μM (MDA-MB-231) and 6.4 μM (4T1 cells). Anticancer agent 253 arrests cell cycle and induces mitochondria-mediated apoptosis in cancer cells. Anticancer agent 253 inhibits Akt phosphorylation in human breast and prostate cancer .
loading...
    loading...
Cat. No.: HY-117782
CAS No.: 1356340-69-6
Target:  

Others

Research Areas:  

Cancer

Anticancer agent 236 (compound JP-8g) is a broad-spectrum anticancer agent that has toxic effects on several cancer cell lines with IC50 values of 6.925 μM (MDA), 6.296 μM (U937), 6.548 μM (Jurkat), 6.373 μM (Hela), and 10.381 μM (EJ) .
loading...
    loading...
Cat. No.: HY-122185
CAS No.: 314022-97-4
Research Areas:  

Cancer

Anticancer agent 211 (AK301) can inhibit tubulin polymerization. Anticancer agent 211 can block the division of human colon cancer cells. Anticancer agent 211 can increase the sensitivity of human colon cancer cells to apoptotic ligands and promote cell apoptosis .
loading...
    loading...
Cat. No.: HY-123715
CAS No.: 1983924-20-4
Target:  

Apoptosis

Research Areas:  

Cancer

Anticancer agent 255 is a monocarbonylated curcumin-1,2,3-oxazole conjugate with significant anticancer activity. The IC50 values of Anticancer agent 255 in prostate cancer cells PC-3 and DU-145 are 8.8μM and 9.5μM respectively. The IC50 values of Anticancer agent 255 against breast cancer cells MCF-7, MDA-MB-231 and 4T1 are 6μM, 10μM and 6.4μM, showing good anti-cancer activity Effect. Anticancer agent 255 can induce mitochondria-mediated apoptosis in cancer cells and prevent cell cycle progression. Anticancer agent 255 down-regulated the cell proliferation marker PCNA and inhibited the activation of cell survival proteins. Anticancer agent 255 up-regulated the pro-apoptotic protein Bax and down-regulated the anti-apoptotic protein Bcl-2 .
loading...
    loading...
Cat. No.: HY-128498
CAS No.: 133342-90-2
Anticancer agent 182 (Compound 1) is a cytotoxic flavonoid compound isolated from the root ofMuntingia colabura L. Anticancer agent 182 exhibits anticancer activity .
loading...
    loading...
Cat. No.: HY-128634
CAS No.: 2235393-30-1
Target:  

Apoptosis PI3K MEK

Research Areas:  

Cancer

CML-IN-1 (compound 7) is a potent anticancer agent. CML-IN-1 displays very good induced-apoptosis effect for human chronic myeloid leukemia (CML) cell line K562. CML-IN-1 exerts its effect via a significantly reduced protein phosphorylation of PI3K/Akt signal pathway. CML-IN-1 (compound 4) also inhibits cell proliferation by suppressing the MEK/ERK signaling pathway in colorectal cancer .
loading...
    loading...
Cat. No.: HY-128689
CAS No.: 146537-05-5
Target:  

Others

Research Areas:  

Cancer

Anticancer agent 3 (Compound 4) is a anti-cancer agent .
loading...
    loading...
Cat. No.: HY-129909
CAS No.: 177951-34-7
Target:  

Apoptosis

Research Areas:  

Infection Cancer

Anticancer agent 173 (compound 19) is a potent thioxodihydroquinazolinone analogs when combined with platinum drugs in inducing apoptotic cancer cells death .
loading...
    loading...